|
Delayed
Nasdaq Stockholm
10:11:34 2026-09-14 am EDT
|
5-day change | 1st Jan Change | ||
| 1.014 SEK | -0.98% |
|
-5.06% | +9.74% |
| Aug. 20 | Intervacc AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Aug. 20 | Calendar Thursday, August 20 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 36.02M | - | ||||
| 66.93B | |||||
| 61.97B | |||||
| 28.26B | - | ||||
| 24.59B | |||||
| 24.3B | - |
- Stock Market
- Stocks
- IVACC Stock
- Charts Intervacc AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
